COMPANY PROFILE · UPDATED 09 JUL 2026

NewLimit

NewLimit specializes in treating age-related diseases to extend the human health span. It works on developing epigenetic reprogramming medicines to treat diseases with large unmet needs.

South San Francisco, CA

newlimit.com ↗

This profile is unclaimed — do you work here? Claim it

Founded: 2022
Headcount: 2
Open roles: 14
Last raised: Series C

NewLimit website

TECH STACK

How NewLimit builds

Sign up to see the tech stack

LEADERSHIP

Founders & key people

Blake Byers

President at PACT Pharma

WomplyPACT PharmaStanford UniversityLendUpArcus BiosciencesIonic SecurityStanford UniversityDuke University

Gregory Johnson

Founder at NewLimit

NewLimitAmazonAllen Institute for Cell ScienceT-MobileCarnegie Mellon UniversityFurther Enterprise Solutions (FES)Ashford UniversityCarnegie Mellon UniversityCalifornia Lutheran UniversityMichigan Technological University

Jacob Kimmel

Researcher

NewLimitCalico Life SciencesUCSFIBMUniversity of Central FloridaNational Institutes of Health (NIH)UCSFUniversity of Central FloridaSatellite High School

Brian Armstrong

CEO at Coinbase Ventures

Coinbase GlobalCoinbase VenturesCoinbase CustodyAirbnbUniversityTutor.comDeloitteRice University

Sign up to see founders

OPEN ROLES

Hiring at NewLimit

View all 14 open roles →

FUNDING

Capital raised

Total raised

$682,245,504

Investors

Funding rounds

Series C
Diffbot knowledge graph
Founders Fund, Lilly Asia Ventures, Kleiner Perkins, Human Capital, Abstract Ventures, Quiet Capital, Nat Friedman, Valor Equity Partners, Thrive Capital, Greenoaks Capital, Daniel Gross
$435MJun 2, 2026
Convertible Note
Diffbot knowledge graph
Human Capital, Dimension Management, Kleiner Perkins, Abstract Ventures, S32, Boost VC, Lilly Ventures, Duke University
$45MOct 20, 2025
Series B
Diffbot knowledge graph
Kleiner Perkins, Khosla Ventures, Dimension Management, Garry Tan, Daniel Gross, Nat Friedman, Human Capital, Founders Fund, Fred Ehrsam, Brian Armstrong, Joshua Kushner, Valor Equity Partners, Joe Lonsdale, John Collison, Patrick Collison, Elad Gil
$130MMay 6, 2025
Series A
Diffbot knowledge graph
Eric Schmidt, Fred Ehrsam, Founders Fund, Dimension Management, Garry Tan, Kleiner Perkins, Elad Gil, Draper Associates
$72.2MMay 16, 2023

Funding data via Diffbot, SEC EDGAR filings and company announcements — each round names its source

Sign up to see capital raised

TAGS

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Investors

Kleiner Perkins Founders Fund Khosla Ventures Quiet Capital

Industries

Software Companies Medical Organizations Biotechnology Companies

LOCATIONS

Where they work

NewLimit offices

Loading map…

South San Francisco, CA901 Gateway Blvd

SIMILAR COMPANIES

Companies like NewLimit

Similar companies

Allara

Series B

Talkiatry

Series D

Create free account to see all similar companies →